VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaccine Detail

Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
Vaccine Information
  • Vaccine Name: Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
  • Target Pathogen: Adenovirus
  • Target Disease: Respiratory infection
  • Product Name: Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
  • Manufacturer: Barr Labs, Inc.
  • Vaccine Ontology ID: VO_0000096
  • CDC CVX code: 143
  • Type: Live vaccine
  • Status: Licensed
  • Location Licensed: United States
  • Host Species for Licensed Use: Human
  • Preparation: Virus is prepared in human-diploid fibroblast cell cultures (strain WI-38). The virus strains have not been attenuated. The virus is harvested and dried. The dry virus material includes monosodium glutamate, sucrose, D-mannose, D-fructose, dextrose, human serum albumin, potassium phosphate and plasdone C (FDA: Adenovirus Vaccine).
  • Immunization Route: orally
  • Storage: Store refrigerated between 2° and 8° C (35° and 46° F). Do not freeze (FDA: Adenovirus Vaccine).
  • Approved Age for Licensed Use: Approved for use in military populations 17-50 years of age (FDA: Adenovirus Vaccine).
  • Contraindication: Pregnancy, allergy to vaccine components, or inability to swallow tablets whole (FDA: Adenovirus Vaccine).
  • Description: Indicated for active immunization for the prevention of febrile acute respiratory disease caused by Adenovirus Type 4 and Type 7, virus strains have not been attenuated. The vaccine is composed of two tablets (one of Adenovirus type 4 and one Adenovirus type 7) designed to pass intact through the stomach and release the live virus in the intestine (FDA: Adenovirus Vaccine).
Host Response
References
FDA: Adenovirus Vaccine: FDA: Adenovirus Vaccine [http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm247508.htm]